MIM
MetLife Investment Management Portfolio holdings
AUM
$17B
1-Year Return
25.61%
This Quarter Return
+7.45%
1 Year Return
+25.61%
3 Year Return
+108.53%
5 Year Return
+194.13%
10 Year Return
–
AUM
$17.4B
AUM Growth
+$604M
(+3.6%)
Cap. Flow
-$359M
Cap. Flow
% of AUM
-2.06%
Top 10 Holdings %
Top 10 Hldgs %
29.23%
Holding
2,954
New
46
Increased
346
Reduced
1,409
Closed
76
Top Buys
| 1 |
Apple
AAPL
|
+$19.3M |
| 2 |
Palantir
PLTR
|
+$18.1M |
| 3 |
Avantor
AVTR
|
+$8.78M |
| 4 |
Dell
DELL
|
+$8.32M |
| 5 |
Broadcom
AVGO
|
+$6.78M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$43.9M |
| 2 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
+$25.3M |
| 3 |
NVIDIA
NVDA
|
+$25.3M |
| 4 |
Microsoft
MSFT
|
+$24.1M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$12.3M |
Sector Composition
| 1 | Technology | 29.87% |
| 2 | Financials | 12.38% |
| 3 | Healthcare | 11.43% |
| 4 | Consumer Discretionary | 10.69% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Goosehead Insurance
GSHD
$2.05B
| $1.13M | 0.01% |
12,670
-862
| -6% | -$77K |
|
1327
Edgewise Therapeutics
EWTX
$1.5B
| $1.13M | 0.01% |
42,271
| – | – |
|
1328
Remitly
RELY
$3.74B
| $1.13M | 0.01% |
84,216
| – | – |
|
1329
Treehouse Foods
THS
$882M
| $1.13M | 0.01% |
26,860
-1,657
| -6% | -$69.6K |
|
1330
Hillenbrand
HI
$1.73B
| $1.13M | 0.01% |
40,543
| – | – |
|
1331
Summit Therapeutics
SMMT
$14.1B
| $1.13M | 0.01% |
51,425
| – | – |
|
1332
Akero Therapeutics
AKRO
$3.48B
| $1.13M | 0.01% |
39,243
| – | – |
|
|
JWN
1333
DELISTED
Nordstrom
JWN
| $1.12M | 0.01% |
49,964
-1,653
| -3% | -$37.2K |
|
1334
DraftKings
DKNG
$21.8B
| $1.12M | 0.01% |
28,543
-23
| -0.1% | -$902 |
|
1335
Trustmark
TRMK
$2.43B
| $1.12M | 0.01% |
35,121
| – | – |
|
1336
CRH
CRH
$76.1B
| $1.12M | 0.01% |
12,040
-271
| -2% | -$25.1K |
|
1337
Extreme Networks
EXTR
$2.95B
| $1.11M | 0.01% |
74,067
| – | – |
|
1338
Cheesecake Factory
CAKE
$2.82B
| $1.11M | 0.01% |
27,406
| – | – |
|
1339
JetBlue
JBLU
$1.84B
| $1.1M | 0.01% |
168,274
-13,482
| -7% | -$88.4K |
|
1340
NeoGenomics
NEO
$1.03B
| $1.1M | 0.01% |
74,807
| – | – |
|
|
B
1341
DELISTED
Barnes Group Inc.
B
| $1.1M | 0.01% |
27,274
| – | – |
|
1342
Amphastar Pharmaceuticals
AMPH
$1.3B
| $1.1M | 0.01% |
22,607
| – | – |
|
1343
Viavi Solutions
VIAV
$2.69B
| $1.1M | 0.01% |
121,539
-5,059
| -4% | -$45.6K |
|
1344
Enterprise Financial Services Corp
EFSC
$2.24B
| $1.1M | 0.01% |
21,375
| – | – |
|
1345
LPL Financial
LPLA
$28.1B
| $1.09M | 0.01% |
4,693
-92
| -2% | -$21.4K |
|
1346
LeMaitre Vascular
LMAT
$2.09B
| $1.09M | 0.01% |
11,739
| – | – |
|
1347
Intapp
INTA
$3.71B
| $1.09M | 0.01% |
22,710
| – | – |
|
1348
Acadia Pharmaceuticals
ACAD
$3.98B
| $1.08M | 0.01% |
70,379
| – | – |
|
1349
Qiagen
QGEN
$9.82B
| $1.08M | 0.01% |
23,270
-42
| -0.2% | -$1.95K |
|
1350
Vanguard Real Estate ETF
VNQ
$34.8B
| $1.08M | 0.01% |
11,100
-3,000
| -21% | -$292K |
|